Atrial fibrillation ablation as first-line therapy for patients with heart failure with reduced ejection fraction (HFrEF): evaluating the impact on patient survival.
Hadi YounesCharbel NoujaimMario MekhaelNour ChoumanAla AssafOmar KreidiehChanho LimNassir F MarroucheEoin DonnellanPublished in: Expert review of cardiovascular therapy (2023)
An appropriate selection strategy for patients with HFrEF could be the next step in determining which patients might benefit most from catheter ablation. Future atrial fibrillation management may incorporate digital health and pulsed-field ablation.
Keyphrases
- catheter ablation
- atrial fibrillation
- left atrial
- left atrial appendage
- end stage renal disease
- oral anticoagulants
- ejection fraction
- healthcare
- newly diagnosed
- public health
- chronic kidney disease
- direct oral anticoagulants
- heart failure
- percutaneous coronary intervention
- prognostic factors
- mental health
- peritoneal dialysis
- case report
- patient reported outcomes
- acute coronary syndrome
- mitral valve
- risk assessment